Table 1.

Demographic and clinical characteristics.

Characteristic	Total (N=262)
Age at diagnosis (years)
Mean (SD)	61.0 (12.3)
Median	61.0
Range	(28 – 93)
FIGO Stage, n (%)
I or II	66 (25.2%)
IIIA or IIIB	12 (4.6%)
IIIC	140 (53.4%)
IV	44 (16.8%)
Grade, n (%)
1	13 (5.2%)
2	25 (9.9%)
3	127 (50.4%)
4	87 (34.5%)
Not documented	10
Histology, n (%)
Clear cell	15 (5.7%)
Endometrioid	47 (17.9%)
Mucinous	10 (3.8%)
Serous	171 (65.3%)
Mixed Epithelial	19 (7.3%)
Debulking status, n (%)
No residual	112 (43.9%)
Optimal (1– 10cm)	110 (43.1%)
Sub-optimal (>10cm)	33 (12.9%)
Unknown	7
Chemo-sensitivity, n (%)
Sensitive	185 (79.7%)
Resistant	47 (20.3%)
Indeterminate †	30

^†The chemo-sensitivity status was indeterminate for 30 patients who either died prior to completion of chemotherapy (n=23) or had less than one year of follow-up with no documented recurrence (n=2 death, n=5 lost to follow-up).